Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Butyrate for Refractory Leg Ulcers in Sickle Cell Disease or Beta Thalassemia
NCT00004412Phase 2Completed
- Start
- Sep 1997
- Primary completion
- Dec 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of arginine butyrate in skin ulcer. Started Sep 1997; status: completed.
02
Drugs
arginine butyrate
03
Conditions
skin ulcer
Beyond the preview
Go deeper on NCT00004412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004412.